Skip to main content
SpringerLink
Log in

Gene Expression Profiling

  • Chapter
  • First Online:
Molecular Pathology of Hematolymphoid Diseases

Part of the book series: Molecular Pathology Library ((MPLB,volume 4))

  • 1287 Accesses

Abstract

Gene expression (GE) analyses by use of microarrays (MAs) have become an important part of biomedical and clinical research and the resulting data may provide important information regarding pathogenesis and be extrapolated for use in diagnosing/prognosticating lymphomas and leukemias. This chapter will first review the various techniques used in gene expression profiling (GEP), and then present the pertinent practical applications of the data acquired by GEP in diagnostic hematopathology, as summarized in various tables, referenced throughout the text.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Haferlach T, Kohlmann A, Kern W, Hiddemann W, Schnittger S, Schoch C. Gene expression profiling as a tool for the diagnosis of acute leukemias. Semin Hematol. 2003;40:281–295

    Article  CAS  PubMed  Google Scholar 

  2. Willman CL. Discovery of novel molecular classification schemes and genespredictive of outcome in leukemia. Hematol J. 2004;5:S138–S143.

    Article  CAS  PubMed  Google Scholar 

  3. Dales JP, Plumas J, Palmerini F, et al. Correlation between apoptosismacroarray gene expression profiling and histopathological lymph nodelesions. J Clin Pathol: Mol Pathol. 2001;54:17–23.

    Article  CAS  Google Scholar 

  4. Staal FJT, van der Burg M, Wessels LFA, et al. DNA microarrays forcomparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers. Leukemia. 2003;17:1324–1332

    Article  CAS  PubMed  Google Scholar 

  5. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840–1847.

    CAS  PubMed  Google Scholar 

  6. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848–1854.

    CAS  PubMed  Google Scholar 

  7. Oscier DG, Gardiner AC, Mould SJ, et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood. 2002;100:1177–1184.

    CAS  PubMed  Google Scholar 

  8. Tchirkov A, Chaleteix C, Magmac C, et al. hTERT expression and prognosis in B-chronic lymphocytic leukemia. Ann Oncol. 2004;15:1476–1480.

    Article  CAS  PubMed  Google Scholar 

  9. Staudt LM. Gene expression profiling. Ann Rev Med. 2002;53:303–318.

    Article  CAS  PubMed  Google Scholar 

  10. Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194:1639–1647.

    Article  CAS  PubMed  Google Scholar 

  11. Orchard JA, Ibbotson RE, Davis Z. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. The Lancet. 2004;363:105–111.

    Article  CAS  Google Scholar 

  12. Ferrer A, Ollila J, Tobin G, et al. Different gene expression in immuoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2004;153:69–72.

    Article  CAS  PubMed  Google Scholar 

  13. Weistner A, Rosenwald A, Barry TS, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profiles. Blood. 2003;101:4944–4951.

    Article  Google Scholar 

  14. Crespo M, Bosch F, Villamor N, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. NEJM. 2003;348:1764–1775.

    Article  CAS  PubMed  Google Scholar 

  15. Rosenberg CL, Motokura T, Kronenberg HM, Arnold A. Coding sequence of the overexpressed transcript of the putative oncogene PRAD1/cyclin D1 in two primary human tumors. Oncogene. 1993;8:519–521.

    CAS  PubMed  Google Scholar 

  16. Pan Z, Shen Y, Du C, et al. Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells. Am J Pathol. 2003;163:135–144.

    CAS  PubMed  Google Scholar 

  17. Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 2003;3:185–197.

    Article  CAS  PubMed  Google Scholar 

  18. Basso K, Liso A, Tiacci E, et al. Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors. J Exp Med. 2004;199:59–68.

    Article  CAS  PubMed  Google Scholar 

  19. Falini B, Tiacci E, Liso A, et al. Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin 1 (ANXA1). The Lancet. 2004;363:1869–1870.

    Article  CAS  Google Scholar 

  20. Glas AM, Kersten J, Delahaye LJMJ, et al. Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood. 2005;105:301–307.

    Article  CAS  PubMed  Google Scholar 

  21. Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. NEJM. 2004;351:2159–2169.

    Article  CAS  PubMed  Google Scholar 

  22. Farinha P, Masoudi H, Skinnider BF, et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood. 2005 (Pubmedline: prepublication)

    Google Scholar 

  23. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–511.

    Article  CAS  PubMed  Google Scholar 

  24. Chang C-C, McClintock S, Cleveland RP, et al. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol. 2004;28(4):464–470.

    PubMed  Google Scholar 

  25. Iqbal J, Sanger WG, Horsman DE, et al. Bc12 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol. 2004;165(1):159–166.

    CAS  PubMed  Google Scholar 

  26. Browne P, Petrosyan K, Hernandez A, Chan JA. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. AJCP. 2003;120:767–777

    CAS  PubMed  Google Scholar 

  27. Garcia-Cosio M, Santon A, Martin P, et al. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin’s lymphoma. Mod Pathol. 2004;17:1531–1538.

    Article  CAS  PubMed  Google Scholar 

  28. Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002;1:133–143.

    Article  CAS  PubMed  Google Scholar 

  29. Ross ME, Zhou X, Song G, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood. 2003;102:2951–2959.

    Article  CAS  PubMed  Google Scholar 

  30. Ferrando AA, Neuberg DS, Staunton JE, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1:75–87.

    Article  CAS  PubMed  Google Scholar 

  31. Ferrando AA, Look AT. Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin Hematol. 2003;40(4):274–280.

    Article  CAS  PubMed  Google Scholar 

  32. Schoch C, Kohlmann A, Schnittger S, et al. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci USA. 2002;99:10008–10013.

    Article  CAS  PubMed  Google Scholar 

  33. Kohlmann A, Dugas M, Shoch C, et al. Gene expression profiles of distinct AML subtypes in comparison to normal bone marrow. Blood. 2001;98:91a (Supplement 1, abstract)

    Google Scholar 

  34. Haferlach T, Kohlmann A, Dugas M, et al. The diagnosis of 14 specific subtypes of leukemia is possible based on gene expression profiles: a study on 263 patients with AML, CML, or CLL. Program and Abstracts of the 44th (2002) Annual Meeting of the American Society of Hematology (Abstract 523)

    Google Scholar 

  35. Schoch C, Kern W, Kohlmann A, et al. Acute myeloid leukemia with a complex aberrant karyotype is a distinct biological entity characterized by genomic imbalances and a specific gene expression profile. Genes Chromosomes Cancer. 2005;43:227–238.

    Article  CAS  PubMed  Google Scholar 

  36. Debernardi S, Lillington DM, Chaplin T, et al. Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events. Genes Chromosomes Cancer. 2003;37:149–158.

    Article  CAS  PubMed  Google Scholar 

  37. Valk PJ, Verhaak RG, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med. 2004;350:1617–1628.

    Article  CAS  PubMed  Google Scholar 

  38. Bullinger L, Dohner K, Bair E, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med. 2004;350:1605–1616.

    Article  CAS  PubMed  Google Scholar 

  39. Ross ME, Mahfouz R, Onciu M, et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood. 2004;104:3679–3687.

    Article  CAS  PubMed  Google Scholar 

  40. Nakao M, Yokota S, Iwai T, et al. Internal tandem duplication of the FLT3 gene found in acute myeloid leukemia. Leukemia. 1996;10:1911–1918.

    CAS  PubMed  Google Scholar 

  41. Gililand DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood. 2002;100:1532–1542.

    Article  Google Scholar 

  42. Levis M, Small D. FLT3: ITDoes matter in leukemia. Leukemia. 2003;17:1738–1752.

    Article  CAS  PubMed  Google Scholar 

  43. Schnittger S, Schoch C, Dugas M, et al. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood. 2002;100:59–66.

    Article  CAS  PubMed  Google Scholar 

  44. Lacayo NJ, Meshinchi S, Kinnunen P, et al. Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes. Blood. 2004;104:2646–2654.

    Article  CAS  PubMed  Google Scholar 

  45. Schnittger S, Kohlmann A, Haferlach T, et al. Acute myeloid leukemia (AML) with partial tandem duplication of the MLL-gene (MLL-PTD) can be discriminated from MLL-translocations based on specific gene expression profiles. Blood. 2002;100:312a (Supplement 1, abstract)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA

    Cherie H. Dunphy MD

Authors
  1. Cherie H. Dunphy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept. Pathology & Laboratory Medicine, University of North Carolina, Chapel Hill, 27599-7525, USA

    Cherie H. Dunphy

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Dunphy, C.H. (2010). Gene Expression Profiling. In: Dunphy, C. (eds) Molecular Pathology of Hematolymphoid Diseases. Molecular Pathology Library, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-5698-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-5698-9_13

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-5697-2

  • Online ISBN: 978-1-4419-5698-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation